{"DataElement":{"publicId":"2861058","version":"2","preferredName":"Serum Beta-2-Microglobulin Protein Laboratory Procedure Performed Result Integer::3 Decimal Place Value","preferredDefinition":"The 3 decimal place numeric laboratory value measured, assigned or computed related to the assessment of serum beta 2 microglobulin in a specimen.","longName":"2861049v1.0:2784515v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2861049","version":"2","preferredName":"Serum Beta-2-Microglobulin Protein Laboratory Procedure Performed","preferredDefinition":"The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins._Beta-2-microglobulin protein (119 aa, ~14 kDa) is encoded by the human B2M gene. This protein plays a role in immune responses and is a key component of major histocompatibility complex class I molecules. The protein is localized to the surface of cells and is utilized as a prognostic marker in persons with cancers that involve white blood cells. The polypeptide is also used as a marker in kidney damage diagnosis and in the detection of viral infection._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.","longName":"2861047v1.0:2828214v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2861047","version":"1","preferredName":"Serum Beta-2-Microglobulin Protein Laboratory Procedure","preferredDefinition":"The clear liquid part of the blood that remains after blood cells and clotting proteins have been removed.:Beta-2-microglobulin protein (119 aa, ~14 kDa) is  encoded by the human B2M gene. This protein plays a role in immune  responses and is a key component of major histocompatibility complex  class I molecules. The protein is localized to the surface of cells and  is utilized as a prognostic marker in persons with cancers that involve  white blood cells. The polypeptide is also used as a marker in kidney  damage diagnosis and in the detection of viral infection.:A medical procedure that involves testing a sample of blood, urine, or other substance from the body. Tests can help determine a diagnosis, plan treatment, check to see if treatment is working, or monitor the disease over time.","longName":"C13325:C62657:C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serum","conceptCode":"C13325","definition":"The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Beta-2-Microglobulin","conceptCode":"C62657","definition":"Beta-2-microglobulin protein (119 aa, ~14 kDa) is encoded by the human B2M gene. This protein plays a role in immune responses and is a key component of major histocompatibility complex class I molecules. The protein is localized to the surface of cells and is utilized as a prognostic marker in persons with cancers that involve white blood cells. The polypeptide is also used as a marker in kidney damage diagnosis and in the detection of viral infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67873AB8-1AB9-E488-E040-BB89AD430F3D","latestVersionIndicator":"Yes","beginDate":"2009-04-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2009-04-14","modifiedBy":"ONEDATA","dateModified":"2009-04-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241241","version":"1","preferredName":"Performed","preferredDefinition":"Performed; carried out.","longName":"C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8839-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E878A7D7-0644-61BF-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2013-10-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2784515","version":"1","preferredName":"Laboratory Procedure Result Integer::3 Decimal Place Value","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Outcome; a phenomenon that follows and is caused by some previous phenomenon._A number with no fractional part, including the negative and positive numbers as well as zero.::3_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.","longName":"LAB_PROC_RSL_3DP_VAL","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":"3","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2784514","version":"1","preferredName":"Laboratory Procedure Outcome Integer::3 Decimal Place Value","preferredDefinition":"A medical procedure that involves testing a sample of blood, urine, or other substance from the body. Tests can help determine a diagnosis, plan treatment, check to see if treatment is working, or monitor the disease over time.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.:A number with no fractional part.::3:An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.:A numerical quantity measured or assigned or computed.","longName":"C25294:C20200:C45255::3:C42646","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Decimal Place","conceptCode":"C42646","definition":"An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56F06815-3EE0-22EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-15","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-15","modifiedBy":"ONEDATA","dateModified":"2008-09-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"56F06815-3EF1-22EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-15","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-15","modifiedBy":"NYCHM","dateModified":"2010-04-09","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964930","version":"1","longName":"2013r1: CLL Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964888","version":"1","longName":"2016r1: Myeloma Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964924","version":"1","longName":"2400r1: Pre-TED","context":"NHLBI"}]},{"publicId":"2842777","version":"1","longName":"Labs","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"10000685","version":"1","longName":"General","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"mye_base_prep_srm_b2_rst","type":"NMDP_FN","context":"NHLBI"},{"name":"mye_base_srm_b2_diag_rst","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedClinicalResult:value","type":"HCT_BRIDG","context":"NHLBI"},{"name":"pre_ted_mm_b2microglb_rst","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_prime_dis_hct_serum_b2_microglob_value","type":"NMDP_FN","context":"NHLBI"},{"name":"cll_base_diag_b2mglb_val","type":"NMDP_FN","context":"NHLBI"},{"name":"cll_base_prep_b2mglb_val","type":"NMDP_FN","context":"NHLBI"},{"name":"LYMpre_dis_assess_prep_serum_b2_microglob_value","type":"NMDP_FN","context":"NHLBI"},{"name":"LYMpre_lab_diag_serum_b2_microglob_value","type":"NMDP_FN","context":"NHLBI"},{"name":"LYMpre_lab_trans_serum_b2_microglob_value","type":"NMDP_FN","context":"NHLBI"},{"name":"PCDpre_lab_diag_serum_b2_microglob_value","type":"NMDP_FN","context":"NHLBI"},{"name":"PCDpre_lab_prep_serum_b2_microglob_value","type":"NMDP_FN","context":"NHLBI"},{"name":"MACpre_lab_diag_serum_b2_microglob_value","type":"NMDP_FN","context":"NHLBI"},{"name":"MACpre_lab_prep_serum_b2_microglob_value","type":"NMDP_FN","context":"NHLBI"},{"name":"CLLP_DALE_srm_b2_microglob_val","type":"NMDP_FN","context":"NHLBI"},{"name":"CLLP_LSDX_srm_b2_microglob_val","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_PCD_srm_b2_microglob_val","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Serum beta 2 microglobulin va","type":"Preferred Question Text","description":"Serum beta 2 microglobulin value:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2861058","type":"BRIDG Mapping Path","description":"PerformedClinicalResult.value(ANY=>PQ).value WHERE PerformedClinicalResult > PerformedObservation > DefinedObservation.nameCode = \"Measure Serum Beta-2-Microglobulin Protein\"","url":null,"context":"NHLBI"},{"name":"What is the value of serum beta 2 microglobulin?","type":"Alternate Question Text","description":"What is the value of serum beta 2 microglobulin?","url":null,"context":"NHLBI"},{"name":"Serum ß2-microglobulin:","type":"Alternate Question Text","description":"Serum ß2-microglobulin:","url":null,"context":"NHLBI"},{"name":"Serum ß2-microglobulin:","type":"Application Standard Question Text","description":"Serum ß2-microglobulin:","url":null,"context":"NHLBI"},{"name":"What is the value of serum ß2 microglobulin?","type":"Alternate Question Text","description":"What is the value of serum ß2 microglobulin?","url":null,"context":"NHLBI"},{"name":"Serum beta2-microglobulin:","type":"Alternate Question Text","description":"Serum beta2-microglobulin:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E878A7D7-079E-61BF-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2013-10-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-11","modifiedBy":"ALEYR","dateModified":"2019-04-07","changeDescription":".Added AQT for 2018. AK 2/25/14. 4/24/14mn-added alt name for 2018r3.. 4/28/14mn-added alt name for 2018r3. 7/22/14mn-added aqt for 2400 w/out symbol. Added human readable def. System generated def displayed as alt def. No version needed. AK 10/22/14 Added alt names for 2019r3. AK 4/11/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}